Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 10/20 | 0.37 |
| ▸ | PTGDR | Q13258 | 4/20 | 0.34 |
| ▸ | FEN1 | P39748 | 9/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 5/20 | 0.33 |
| ▸ | CEL | P19835 | 1/20 | 0.32 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19986379 | 0.94 | FEN1 (0.35) | PTGDR2PTGDRFEN1ALOX5AP | |
| SCHEMBL19986360 | 0.91 | PTGDR2 (0.32) | PTGDR2 | |
| SCHEMBL15233512 | 0.84 | — | — | |
| SCHEMBL172160 | 0.84 | ESR2 (0.31) | — | |
| SCHEMBL15684612 | 0.81 | PTGDR2 (0.35) | PTGDR2PTGDRFEN1ALOX5APCEL | |
| SCHEMBL19985267 | 0.81 | — | — | |
| SCHEMBL20052525 | 0.80 | HTR2C (0.41) | PTGDR2PTGDR | |
| SCHEMBL19985586 | 0.80 | — | — | |
| SCHEMBL10017841 | 0.79 | CYP2C9 (0.35) | — | |
| SCHEMBL27952428 | 0.78 | CEL (0.44) | PTGDR2FEN1ALOX5APCEL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873438-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2024-01-16 | — | — | US | disclosed |
| US-11718791-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | MERCK PATENT GMBH (DE) | 2023-08-08 | — | — | US | disclosed |
| US-20230242817-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POYLMERIZABLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-08-03 | — | — | US | disclosed |
| US-20210348056-A1 | Polymerisable Compounds and the Use thereof in Liquid-Crystal Displays | MERCK PATENT GMBH (DE) | 2021-11-11 | — | — | US | disclosed |
| US-11072742-B2 | Liquid-crystalline media having homeotropic alignment | MERCK PATENT GMBH (DE) | 2021-07-27 | — | — | US | disclosed |
| US-11008515-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2021-05-18 | — | — | US | disclosed |
| US-20210139781-A1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2021-05-13 | — | — | US | disclosed |
| US-10934487-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2021-03-02 | — | — | US | disclosed |
| US-20200291298-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2020-09-17 | — | — | US | disclosed |
| US-10759996-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2020-09-01 | — | — | US | disclosed |
| US-10676671-B2 | Method of reducing ODF mura in polymer stabilised liquid crystal displays | MERCK PATENT GMBH (DE) | 2020-06-09 | — | — | US | disclosed |
| US-10642104-B2 | Method of controlling the pretilt angle in polymer stabilised liquid crystal displays | MERCK PATENT GMBH (DE) | 2020-05-05 | — | — | US | disclosed |
| US-20190185754-A1 | LIQUID-CRYSTALLINE MEDIA HAVING HOMEOTROPIC ALIGNMENT | MERCK PATENT GMBH (DE) | 2019-06-20 | — | — | US | disclosed |
| US-20190161679-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2019-05-30 | — | — | US | disclosed |
| US-20180201837-A1 | Method of Reducing ODF Mura in Polymer Stabilised Liquid Crystal Displays | MERCK PATENT GMBH (DE) | 2018-07-19 | — | — | US | disclosed |
| US-9944416-B2 | Filling device and use thereof for dispensing a fluid | MERCK PATENT GMBH (DE) | 2018-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718791-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | VCL, ILK, LCP1 | PTGDR2 2714/4885PTGDR 2916/4885FEN1 3541/4885 |
| US-20210139781-A1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | VCL, ILK, LCP1 | PTGDR2 2714/4885PTGDR 2916/4885FEN1 3541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.